CISCRP Clinical Trial Results Summaries
The Trial Results Summaries below were prepared by CISCRP in collaboration with the study sponsor and reviewed for scientific accuracy. The summaries “translate” the technical trial results posted on clinicaltrials.gov into easy-to-understand language. For more information on CISCRP’s Clinical Trial Results program please contact us.
| Research Sponsor: Pfizer Drug Studied: Pregabalin (Lyrica®) National Clinical Trial #:NCT01057693 Protocol #: A0081242 Study Date: March 2010 to January 2012 View CISCRP Clinical Trial Results Summary
Full scientific report available at |
| Research Sponsor: Eli Lilly and Company Drug Studied: Duloxetine (Cymbalta®) National Clinical Trial #: NCT01018680 Protocol #: F1J-US-HMGL Study Date: November 2009 to April 2011 View CISCRP Clinical Trial Results Summary
Full scientific report available at www.clinicaltrials.gov/show/results/NCT01018680 |
| Research Sponsor: Eli Lilly and Company Research Collaborator: Genentech Drug Studied: Gemcitabine (Gemzar®) plus Bevacizumab (Avastin®) National Clinical Trial #: NCT00623233 Protocol #: B9E-US-S379 Study Date: March 2008 to January 2011 View CISCRP Clinical Trial Results
Full scientific report available at www.clinicaltrials.gov/show/results/NCT00623233 |
| Research Sponsor: Pfizer Drug Studied: Toviaz®/ fesoterodine fumarate National Clinical Trial #: NCT00611026 Protocol #: A0221046 Study Date: APRIL 4, 2008 to OCTOBER 20, 2009 View CISCRP Clinical Trial Results
Full scientific report available at www.clinicaltrials.gov/show/results/NCT00611026
Listen to the CISCRP trial results summary by calling 1-877-538-7460. This is a toll-free number. |
